Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
766.00Prev. Close
765.05Volume
3,47,357Total traded value
26.98 CrUpper Circuit
918.05Lower Circuit
612.05Fundamentals
| Market Cap | ₹3,527Cr |
| ROE | 10.70% |
| P/E Ratio(TTM) | 41.15 |
| EPS(TTM) | 18.61 |
| P/B Ratio | 4.33 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.73 |
| Book Value | 176.75 |
| Debt to Equity | 0.30 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Senores Pharmaceuticals
Senores Pharmaceuticals is a global company that serves regulated markets, with a large part of its product portfolio catering to government contracts and controlled substances. The company operates with a core mission of being committed to global wellness, aiming to provide quality healthcare products worldwide. In the first quarter of FY26, the company's profit after tax impressively grew by 95% compared to the previous year.;
| Parent Organisation | Senores Pharmaceuticals |
| NSE Symbol | SENORES |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Top Mutual Funds Invested(4)
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.50 | ||
| Ajanta Pharma | NA (0.00%) | 33.07 | ||
| Gland Pharma | NA (0.00%) | 38.55 | ||
| Eris Lifesciences | NA (0.00%) | 52.89 |